Adverse Event Clinical Trial
Official title:
Comparison of Esketamine Versus Sevoflurane Add to Dexmedetomidine-based Sedation for Minor Ophthalmology Procedure in Children: A Randomized Controlled Trial.
Verified date | March 2024 |
Source | Eye & ENT Hospital of Fudan University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Emergence agitation is the most common reason for post-anesthesia care unit delay. Sevoflurane is used frequently inhalational anaesthetic agent to provide pediatric anaesthesia because of the nonirritant nature. It has been successfully used for keeping spontaneous breathing without tracheal intubation. However, sevoflurane may cause emergence agitation as the incidence varied from 10%-80%. Although there are many sedative agents to reduce its incidence, such as propofol, midazolam, a2 adrenergic receptor agonists and ketamine, the efficacy remains limited. Ketamine, a neuroleptic anesthetic agent, contains two optical isomers, s(+)-ketamine (esketamine) and R(-)-ketamine. Esketamine is a right-handed split of ketamine, which has enhanced analgesic potency and lower incidence of psychotropic side effects compared to ketamine. It stimulate breathing due to N-Methyl-D-Aspartate receptor blockade, and could even effectively countered remifentanil-induced respiratory depression. The investigators compared the effectiveness of esketamine and sevoflurane in reducing the incidence of emergence agitation after painless ophthalmological procedure in pediatric patients.
Status | Completed |
Enrollment | 116 |
Est. completion date | May 17, 2023 |
Est. primary completion date | May 14, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 3 Months to 5 Years |
Eligibility | Inclusion Criteria: - American Society of Anesthesiologists physical status 1-2 - required to remove the stitches by microscope after corneal surgeries Exclusion Criteria: - psychiatric disorders - cardiovascular disorders - glaucoma - contraindications to nasal intubation |
Country | Name | City | State |
---|---|---|---|
China | Anesthesiology Department of Affiliated Eye and ENT Hospital, Fudan University | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Eye & ENT Hospital of Fudan University |
China,
Cravero J, Surgenor S, Whalen K. Emergence agitation in paediatric patients after sevoflurane anaesthesia and no surgery: a comparison with halothane. Paediatr Anaesth. 2000;10(4):419-24. doi: 10.1046/j.1460-9592.2000.00560.x. — View Citation
Eich C, Verhagen-Henning S, Roessler M, Cremer F, Cremer S, Strack M, Russo SG. Low-dose S-ketamine added to propofol anesthesia for magnetic resonance imaging in children is safe and ensures faster recovery--a prospective evaluation. Paediatr Anaesth. 2011 Feb;21(2):176-8. doi: 10.1111/j.1460-9592.2010.03489.x. No abstract available. — View Citation
Liao R, Li JY, Liu GY. Comparison of sevoflurane volatile induction/maintenance anaesthesia and propofol-remifentanil total intravenous anaesthesia for rigid bronchoscopy under spontaneous breathing for tracheal/bronchial foreign body removal in children. Eur J Anaesthesiol. 2010 Nov;27(11):930-4. doi: 10.1097/EJA.0b013e32833d69ad. — View Citation
Patrizi A, Picard N, Simon AJ, Gunner G, Centofante E, Andrews NA, Fagiolini M. Chronic Administration of the N-Methyl-D-Aspartate Receptor Antagonist Ketamine Improves Rett Syndrome Phenotype. Biol Psychiatry. 2016 May 1;79(9):755-764. doi: 10.1016/j.biopsych.2015.08.018. Epub 2015 Aug 24. — View Citation
Welborn LG, Hannallah RS, Norden JM, Ruttimann UE, Callan CM. Comparison of emergence and recovery characteristics of sevoflurane, desflurane, and halothane in pediatric ambulatory patients. Anesth Analg. 1996 Nov;83(5):917-20. doi: 10.1097/00000539-199611000-00005. — View Citation
White PF, Schuttler J, Shafer A, Stanski DR, Horai Y, Trevor AJ. Comparative pharmacology of the ketamine isomers. Studies in volunteers. Br J Anaesth. 1985 Feb;57(2):197-203. doi: 10.1093/bja/57.2.197. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the incidence of respiratory depression | respiratory rate <12 times per min or weak chest undulation | duration from the time patient received induction to the time of leaving to the ward, average 1 hour | |
Primary | the incidence of desaturation | the incidence of oxygen saturation below 95% caused by anesthetic agent. | duration from the time patient received induction to the time of leaving to the ward, average 1 hour | |
Primary | the incidence of hypotension | the incidence of systolic blood pressure< 30% of basal systolic blood pressure and lasted >5 minutes. | duration from the time patient received induction to the end of the anesthesia, average 15 minutes. | |
Primary | the incidence of hypertension | the incidence of systolic blood pressure > 30% of basal systolic blood pressure | duration from the time patient received induction to the end of the anesthesia, average 15 minutes. | |
Primary | the incidence of tachycardia | the incidence of heart rate increase over 30% of pre-induction and>120 beats per minute. | duration from the time patient received induction to the end of the anesthesia, average 15 minutes. | |
Primary | the incidence of bradycardia | the incidence of heart rate less than 60 beats per minute | duration from the time patient received induction to the end of the anesthesia, average 15 minutes. | |
Primary | the incidence of emergence agitation | the incidence of emergence agitation | duration from the time patients arrived the post-anesthesia care unit to the time of leaving to the ward, average 20 minutes | |
Secondary | length of stay in the post-anesthesia care unit | the time of patients staying in post-anesthesia care unit | duration from the time patients arrived the post-anesthesia care unit to the time of leaving to the ward, average 20 minutes | |
Secondary | CPS score | The Cole 5-point scale CPS) score included five behaviors: 1=sleeping; 1=awake,calm;3=irritable, crying;4=inconsolable crying; 5=severe restlessness, disorientation. | scores at the time point of 1 minutes after extubation | |
Secondary | intraocular pressure | intraocular pressure after induction | the time after intubation and topical anesthesia within 1 minute | |
Secondary | diastolic pressure | diastolic pressure | 1minutes before induction; 1minutes before intubation; 1minutes after intubation; 3 minutes after intubation | |
Secondary | systolic pressure | systolic pressure | 1minutes before induction; 1minutes before intubation; 1minutes after intubation; 3 minutes after intubation | |
Secondary | heart rate | heart rate | 1minutes before induction; 1minutes before intubation;1minutes after intubation,3 minutes after intubation | |
Secondary | extubation time | extubation time | duration from the time that patients arrived in post-anesthesia care unit to the time of extubation, average 10 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03668639 -
Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin
|
Phase 2/Phase 3 | |
Completed |
NCT05232656 -
PREventing Adverse Events Post-Discharge Through Proactive Identification, Multidisciplinary Communication, and Technology
|
N/A | |
Completed |
NCT03482232 -
Consequences of Doing What Should Not be Done in Primary Care
|
||
Completed |
NCT05693051 -
Use of Prone Position Ventilation in Danish Patients With COVID-19 Induced Severe ARDS Treated With VV-ECMO
|
||
Completed |
NCT04055363 -
Human Milk Oligosaccharides (HMOs) Post-market Study on Infants
|
N/A | |
Completed |
NCT05133817 -
Prophylactic Norepinephrine Infusion Combined With Colloid Coloading for Postspinal Anesthesia Hypotension
|
N/A | |
Completed |
NCT02996201 -
Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT05462938 -
Conscious Sedation for Transcatheter Aortic Valve Implantation
|
N/A | |
Completed |
NCT04562922 -
LIFEMEL Efficacy in Preventing Haematopoietic Toxicity in Patients Treated With Chemotherapy
|
Phase 2 | |
Recruiting |
NCT03740464 -
Long-acting G-CSF for Febrile Neutropenia
|
Phase 3 | |
Completed |
NCT03332433 -
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Gastroscopy Sedated by Propofol
|
N/A | |
Not yet recruiting |
NCT04615156 -
18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography
|
Phase 3 | |
Recruiting |
NCT03381534 -
Safety and Efficacy of Distal Embolic Protection Device in Vertebral Artery Origin Stenting
|
N/A | |
Completed |
NCT04570488 -
Predicting Favorable Outcomes in Hospitalized Covid-19 Patients
|
||
Recruiting |
NCT05369962 -
Adverse Event Prediction in Geriatric Patients in the ED With Ultrasound
|
||
Withdrawn |
NCT03673566 -
Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - CHMCO
|
N/A | |
Completed |
NCT03745677 -
Redesigning Systems to Improve Quality for Hospitalized Patients
|
N/A | |
Completed |
NCT04763876 -
Intramuscular Ketorolac at Two Single-Dose Regimens
|
Phase 4 | |
Withdrawn |
NCT03673579 -
Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - MHSB
|
N/A | |
Enrolling by invitation |
NCT05443217 -
Relationship Between Microbiota and Prognosis of Hepatocellular Carcinoma(HCC) After Systemic Treatments
|